|
Jan 11
|
Algernon Pharmaceuticals Announces Notice of Allowance for Ifenprodil Patent in Japan for Idiopathic Pulmonary Fibrosis
|
|
Dec 27
|
Algernon Pharmaceuticals Announces Closing of Private Placement
|
|
Dec 27
|
Algernon Pharmaceuticals Announces Increase to Private Placement
|
|
Nov 30
|
Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat NASH and NAFLD
|
|
Aug 8
|
Algernon NeuroScience Announces 40 Patient Phase 2 Psychedelic Drug DMT Stroke Study
|